secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2022-09-20T23:59:59+00:00
Accession:  0001818382-22-000172
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte appoints Lt. Gen. Bruce Green to board and Cindy Cao as CRO
--------------------------------------------------------------------

- Green, former U.S. Air Force Surgeon General, joins Board as Class I director.
- Cao appointed Chief Regulatory Officer; prior SVP at Ascentage Pharma and roles at BMS, Novartis.
- Outgoing CRO Bill Tente remains as Executive Advisor on regulatory initiatives.
- Green receives $50K annual cash retainer (pro-rated) and option for 13,000 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000181838222000172/0001818382-22-000172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000181838222000172/huma-20220915.htm
  HTML page:      https://secwatch.observer/filing/0001818382-22-000172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer